FTC Grants Early Termination for Servier's Tender Offer for Day One Bio

summarizeSummary

The FTC has granted early termination of the HSR waiting period, fulfilling a major regulatory condition for Servier's acquisition of Day One Biopharmaceuticals.

check_boxKey Events

• HSR Waiting Period Terminated

  The Federal Trade Commission (FTC) granted early termination of the waiting period under the HSR Act on April 7, 2026, at 1:37 p.m., Eastern Time.

• Key Acquisition Condition Met

  This action satisfies a critical regulatory condition for Servier's tender offer to acquire Day One Biopharmaceuticals, moving the acquisition closer to completion.

auto_awesomeAnalysis

This amendment confirms that the Federal Trade Commission (FTC) has granted early termination of the HSR Act waiting period, effective April 7, 2026. This satisfies a key regulatory condition for Servier's tender offer to acquire Day One Biopharmaceuticals, removing a significant hurdle for the acquisition to proceed. Investors should monitor the remaining conditions for the offer's completion.